1652123660  

Pharmacogenomics in Psychiatry

Englisch

Basel : Karger, 2010

Online-Ressource (VIII, 140 S)

Literaturangaben

Druckausg.: Schwab, Matthias *1963-*: Pharmacogenomics in psychiatry. - Basel : Karger, 2010. - VIII, 139 S.

978-3-8055-9499-8

978-3-8055-9498-1

Weitere Ausgaben: 978-3-8055-9498-1 (Druckausgabe)

One tablet or two? : towards the development of pharmacogenomically informed drug dose individualization / Kirchheiner, J. ... [et al.]Pharmacogenomics : reflecting on the old and new social, ethical and policy issues in postgenomics medicine / Ozdemir, V.

Pharmacogenomics and personality : role of CYP2D6 and implications for psychopathology / Peñas-LLedó, E.M.; Dorado, P.; Llerena, A.

Pharmacogenetics of schizophrenia : bringing 'order to chaos' in the psychopharmacology of schizophrenia? / Buckley, P.F.; Miller, D.D.; Foster, A.

Pharmacogenomics of depression / Serretti, A.; Drago, A.; Spina, E.

Pharmacogenomics of attention-deficit/hyperactivity disorder / Froehlich, T.; Stein, M.A.

Pharmacogenomics of eating disorders / Monteleone, P.; Maj, M.

Future of personalized prescription in psychiatry / de Leon, J.

*Psychopharmakotherapie

*Clinical Chemistry ; General Medicine ; Human Genetics ; Laboratory ; Neurology ; Pharmacology ; Preventive Medicine ; Psychiatry ; Social Medicine

*Psychotropic Drugs ; Mental Disorders ; Mental Disorders ; Pharmacogenetics

*Psychiatry ; Clinical Chemistry ; General Medicine ; Human Genetics ; Laboratory ; Neurology ; Pharmacology ; Preventive Medicine ; Social Medicine ; Mental illness / Chemotherapy ; Mental illness / Genetic aspects ; Pharmacogenomics ; Mental Disorders / drug therapy ; Mental Disorders / genetics ; Pharmacogenetics / methods ; Psychotropic Drugs / pharmacokinetics

W1 ; WM 402

Klassifikation der Library of Congress: RC483

Dewey Dezimal-Klassifikation: 616.89/061; ; 616.89061;

Regensburger Verbund-Klassifikation: XI 5803: X-Y Medizin / XI Pharmakologie und Toxikologie / XI 2900-XI 9099 Spezielle Pharmakologie und Toxikologie / XI 5300-XI 5999 Nervensystem und Sinnesorgane (Neuropharmakologie) / XI 5800-XI 5899 Psychopharmaka, Rauschgifte / XI 5801-XI 5828 A. Formalschlüssel / Kompendien, Repetitorien, Leitfäden, Kurzdarstellungen, programmierter Unterricht

In recent years, there have been major developments in the fields of pharmacogenetics and pharmacogenomics, with the potential to make drug treatments in psychiatric medicine more effective. However, improvements in drug efficacy and tolerability, as well as finding the optimal dosage, can only be realized if in vivo mechanisms of drug action and ADME (absorption, distribution, metabolism, excretion) processes (pharmacokinetics) of psychopharmacological agents are better understood. In this volume, current progress and perspectives in pharmacogenetic testing of drug-metabolizing enzymes, drug transporters and other drug targets involved in the response to psychotropic agents are described extensively. This provides a timely overview of what has been achieved in the area of psychiatric pharmacogenomics alongside some promising directions and perspectives for future research.Psychiatrists, general medical doctors as well as pharmacologists and clinical pharmacologists will find new insights into the development and applications of pharmacogenomics in psychiatry

 

Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt.